Q4 2024 Earnings Call Transcript March 25, 2025 X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line ...

In the assessment of 12-month price targets, analysts unveil insights for X4 Pharmaceuticals, presenting an average target of ...

GameSir X4 Aileron: one-minute review. T he GameSir X4 Aileron is a mobile controller purpose-built for cloud gaming on an Android phone, turning your device into a glorified hand ...

Reports Q4 revenue $1.4M vs. $0 last year. “As expected, 2024 was a transformative year for the company and our momentum has continued into ...

X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...

Before thousands of people flock to downtown Salt Lake City to attend the Qualtrics X4 summit, the Provo-born company on ...

If you buy something via one of our links, we may earn a commission. As a massive fan of the Insta360 X3, I was thrilled when a brand-new X4 arrived at my doorstep for testing earlier this season. The ...

Recently Radxa released the X4, which is an SBC containing not only an N100 x86_64 SoC but also an RP2040 MCU connected to a Raspberry Pi-style double pin header. The Intel N100 is one of a ...

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.

BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss ...